Nanotechnology plays a pivotal role in enhancing the sensitivity and specificity of liquid biopsies. By employing nanoparticles, nanotubes, and other nanoscale materials, researchers can improve the detection and quantification of biomarkers such as circulating tumor cells (CTCs) and cell-free DNA (cfDNA) at very low concentrations.
